Company Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.
The company’s Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours.
The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally.
Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Country | United States |
Founded | 2000 |
IPO Date | May 15, 2007 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 3,000 |
CEO | James Hollingshead |
Contact Details
Address: 100 Nagog Park Acton, Massachusetts 01720 United States | |
Phone | 978 600 7000 |
Website | insulet.com |
Stock Details
Ticker Symbol | PODD |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001145197 |
CUSIP Number | 45784P101 |
ISIN Number | US45784P1012 |
Employer ID | 04-3523891 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Dr. James R. Hollingshead Ph.D. | President, Chief Executive Officer and Director |
Lauren Budden | Group Vice President, Chief Accounting Officer and Controller |
Mark Field | Senior Vice President and Chief Technology Officer |
Eric Benjamin | Executive Vice President, Chief Product and Customer Experience Officer |
Ana Maria Chadwick | Executive Vice President, Chief Financial Officer and Treasurer |
Prem Singh | Senior Vice President of Global Operations |
Deborah R. Gordon CPA | Vice President of Investor Relations |
Laetitia Cousin | Senior Vice President of Regulatory Affairs, Quality Assurance and Compliance |
Angela Geryak Wiczek | Senior Director of Corporate Communications |
Philip Hildale | Senior Vice President of Sales and Customer Care |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 12, 2024 | 144 | Filing |
Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Nov 8, 2024 | 10-Q | Quarterly Report |
Nov 7, 2024 | 8-K | Current Report |
Oct 7, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Sep 11, 2024 | 144 | Filing |
Sep 10, 2024 | 144 | Filing |
Sep 9, 2024 | 144 | Filing |
Sep 9, 2024 | 144 | Filing |
Aug 30, 2024 | 144 | Filing |